phrykt

OKYO Pharma Ltd (OKYO): who owns it and who trades it

As of Nov 16, 2026, OKYO insiders reported 7 purchases worth $136K in the last 12 months. The largest buyer was Gabriele M Cerrone (Director), with $67.6K. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling OKYO Pharma

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, OKYO insiders reported $136K of open-market purchases and $0 of sales.

Purchases, 12 months
$136K
7 trades, 6 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Jul 27, 2026
Filed Aug 7, 2026

Purchases and sales by month

$136K$136KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 27, 2026Rajkumar V. PatilChief Scientific OfficerPurchase3,363$1.49$5KForm 4
Jul 22, 2026Robert John DempseyCEOPurchase15,000$1.54$23.1KForm 4
Jul 21, 2026John P BrancaccioDirectorPurchase5,000$1.48$7.4KForm 4
Jul 21, 2026Gary S JacobDirectorPurchase3,500$1.40$4.9KForm 4
Jul 21, 2026Flavio MantelliCHIEF MEDICAL OFFICERPurchase20,000$1.40$28KForm 4
Jul 21, 2026Gabriele M CerroneDirectorPurchase22,500$1.45$32.6KForm 4
Jul 20, 2026Gabriele M CerroneDirectorPurchase25,000$1.40$35KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Gabriele M CerroneDirector, 10% owner$67.6K–Jul 21, 2026
Flavio MantelliCHIEF MEDICAL OFFICER$28K–Jul 21, 2026
Robert John DempseyCHIEF EXECUTIVE OFFICER, Director$23.1K–Jul 22, 2026
John P BrancaccioDirector$7.4K–Jul 21, 2026
Rajkumar V. PatilChief Scientific Officer$5K–Jul 27, 2026
Gary S JacobCHIEF DEVELOPMENT OFFICER, Director$4.9K–Jul 21, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

OKYO short interest

Low short interest. 0.1% of OKYO shares are sold short: about 1 share in 1,151. Over the last 12 reports the number of shares short went down 72%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 45,609 OKYO shares were sold short, 0.1% of the shares outstanding, down 40.5% from the report before. At the average daily volume of 54,910 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.09%Jul 15Oct 300.29%

Days to cover

1.0May 15Oct 303.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202645,6090.09%-40%54,9101.0
Oct 15, 202676,6520.15%+121%42,9291.8
Sep 30, 202634,6430.07%-18%76,3161.0
Sep 15, 202642,1410.08%-22%91,7851.0
Aug 31, 202654,2690.10%-35%64,1331.0
Aug 14, 202683,4500.16%-38%69,3821.2
Jul 31, 2026135,3700.26%+223%144,7001.0
Jul 15, 202641,8620.08%+29%189,0491.0
Jun 30, 202632,380–-61%64,9161.0
Jun 15, 202682,735–-34%62,8501.3
May 29, 2026124,433–-24%48,5272.6
May 15, 2026162,711–-38%51,3013.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold OKYO

1 of the 50 well-known investors we track reported holding OKYO in their latest 13F filing. The largest position is Ken Griffin's, worth $47.7K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202636,964$47.7K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about OKYO Pharma Ltd (OKYO) stock

Are OKYO insiders buying or selling?

In the last 12 months, OKYO insiders reported 7 open-market purchases worth $136K and no sales. The latest trade was on Jul 27, 2026. See every trade.

What is the short interest in OKYO?

As of Oct 30, 2026, 45,609 OKYO shares were sold short, 0.1% of the shares outstanding, down 40.5% from the report before. At the average daily volume of 54,910 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold OKYO?

1 of the 50 well-known investors we track reported OKYO in their latest 13F filing, including Ken Griffin. The largest position is worth $47.7K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.